We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Short-Term Forecasts Sample Clauses

Short-Term Forecasts. Upon execution of this Agreement, and thereafter at least thirty (30) days prior to the first (1st) day of each succeeding calendar quarter, Rugby will furnish HMRI with a rolling forecast of the quantities of each Product, by package size (SKU) and finished dosage form, that Rugby intends to order during the twelve (12) month period commencing with that calendar quarter, stipulating periodic delivery requirements. The first three months of such forecast shall constitute a binding commitment of Rugby to purchase such quantities evidenced by purchase orders to HMRI pursuant to Section 2.6 herein. In the event it is reasonably necessary for HMRI to purchase active ingredient for Product beyond the binding commitment of Rugby, HMRI may request written authorization from Rugby regarding such purchase. In the event Rugby authorizes such purchase, or authorizes a portion of such purchase, Rugby will be responsible for the costs of the active ingredient authorized to be purchased which is not used by HMRI in the manufacture of Product or other products. In the event Rugby does not authorize such purchase, HMRI shall not be required (but shall use commercially reasonable efforts) to meet Rugby's forecasts or orders with respect to the Products manufactured with such active ingredient. Rugby will be required to purchase that percentage of the quantity of each Product specified in the short-term forecast for successive quarters as follows: Percentage of Product indicated Three Month Period in the forecast that Rugby is of the forecast is required to purchase --------------- ----------------------- First 100% Second 50% over the next three quarters
Short-Term Forecasts. (a) Periods Covered By and Delivery Dates for Short-Term Forecasts. Synthelabo shall also provide PRAECIS with short-term forecasts of its good-faith estimate of its requirements for Licensed Products on a rolling five calendar quarter basis (i.e., covering five successive calendar quarters from January-March, April-June, July-September and October-December, as applicable) (each a "Short-Term Forecast"). The initial Short-Term Forecast shall be delivered to PRAECIS simultaneously with the initial Long-Term Forecast to be delivered six months prior to the Startup Date pursuant to the first sentence of Section 3.3 above, and shall cover the calendar quarter in which the Startup Date occurs and the next four succeeding calendar quarters. Each subsequent Short-Term Forecast shall be delivered to PRAECIS not later than the first day of each succeeding calendar quarter. (b) Binding Estimates. Each Short-Term Forecast shall be provided at least six months in advance of the commencement of the five-quarter period covered by such Short-Term Forecast. The forecast for the first calendar quarter covered by each Short- Term Forecast shall be treated as a binding forecast with respect to such quarter (each a "Binding Estimate"), subject to the remaining provisions of this Article 3. Each Short-Term Forecast shall revise and update the projections set forth in the applicable Long-Term Forecast. (c) Synthelabo's Purchase Commitment Based on Binding Estimates. Subject to the provisions of Section 3.7 below, Synthelabo's delivery to PRAECIS of each Short-Term Forecast shall constitute Synthelabo's binding commitment to purchase during the first calendar quarter covered thereby at least 80% of the Binding Estimate contained in such Short-Term Forecast.
Short-Term ForecastsAt the time that HMRI first reasonably expects that it will require Material for Clinical Work or commercial sale within the ensuing 12 month period, and thereafter, at least 30 days prior to the first day of each succeeding calendar quarter, HMRI shall furnish Alliance with a rolling forecast of the quantities of Material that HMRI intends to order by month, for the first six months, and by quarter, for the last six months, during the 12 month period commencing with that calendar quarter. Such forecasts shall constitute binding commitments of HMRI to purchase the percentages of Material set forth below. An example of form for the short-term forecast is set out in Exhibit 1 (forecasts 1 and 2). The binding commitment of HMRI to purchase the forecasted quantities for the first three months of the forecast shall be further evidenced by purchase orders to be issued to Alliance in accordance with Section 2.3. HMRI shall be required to purchase that percentage of the quantity of Material specified in the forecast for successive quarters as follows: Percentage of Material Period indicated in Forecast that of the Forecast HMRI is Required to Purchase ----------------- ---------------------------- **
Short-Term Forecasts. By the 20th of the month, CAMD will supply SANYO with a non-binding forecast of its demand for wafer starts during the following three months. The quantity variation in the short term forecast shall be ** for the 1st, 2nd and 3rd month, respectively. SANYO will respond within the following four (4) business days as to whether it has the capacity to meet such forecast. If SANYO responds that it has adequate capacity, then it will reserve such capacity for CAMD.
Short-Term Forecasts. Once commercial production of POC Rapid Assays is set to commence, SYN.X shall provide to PBM no later than 90 days prior to the first day of each succeeding calendar quarter a rolling forecast of the quantities of POC Rapid Assays that SYN.X intends to order by month, during the next calendar quarter. Such forecasts shall constitute binding commitments of SYN.X to order and PBM to supply at least 80% of the number of POC Rapid Assays designated, pursuant to firm orders issued in accordance with the terms of this Agreement.
Short-Term Forecasts. Upon execution of this AGREEMENT, and thereafter no later than the tenth (10th) calendar day of any calendar month (the "FORECAST MONTH") (with the previous month's forecast to govern in the event of the failure or delay of such delivery), MEDICIS shall deliver to HMR GmbH a rolling monthly forecast of the quantities of each HMR MANUFACTURED PRODUCT, by finished dosage form and package size (SKU), that MEDICIS intends to order during the ensuing twenty four (24) month period (including the FORECAST MONTH) after receipt by HMR GmbH of the forecast. It is acknowledged that the monthly forecasts in the 24-MONTH FORECAST for the period from the LICENSE EFFECTIVE DATE through the end of the third (3rd) full calendar month following the LICENSE EFFECTIVE DATE shall constitute confirmed MEDICIS orders for purposes of this AGREEMENT. HMR GmbH shall within ten (10) business days following its receipt of each forecast confirm in writing, in whole or in part, the quantities of HMR MANUFACTURED PRODUCT that HMR GmbH shall supply hereunder, and such confirmation shall pertain only to the third (3rd) month after the FORECAST MONTH. HMR GmbH may elect not to confirm, in whole or in part, any forecast which (i) is made at a time when HMR has the right to suspend the provision of HMR MANUFACTURED PRODUCTS pursuant to Section 2.12(b) hereof, (ii) cannot be filled due to circumstances arising under Section 8.1, (iii) are in excess of the quantities forecasted by 13 SUPPLY AGREEMENT MEDICIS in the 24-MONTH FORECAST (which quantities HMR GmbH may, at its option, apportion pro rata among each month in a calendar quarter in the 24-MONTH FORECAST for purposes of this clause), or (iv) relates to any period of time beyond the 24-MONTH FORECAST. All rejections, in whole or in part, of MEDICIS orders by HMR GmbH must be in writing and delivered within such ten (10) business day confirmation period. By virtue of HMR GmbH's written confirmation and to the extent of such written confirmation, the forecast for such third (3rd) calendar month after the FORECAST MONTH shall become a binding obligation on MEDICIS to purchase, and a binding obligation on HMR GmbH to supply, such quantities. MEDICIS' first short term forecast (the "24-MONTH FORECAST") is attached hereto as Exhibit D. Unless mutually agreed by HMR GmbH and MEDICIS in writing, MEDICIS shall be required to purchase that percentage of the quantity of each HMR MANUFACTURED PRODUCT specified in each short-term forecast for successi...
Short-Term Forecasts. NCPA will develop all short-term forecasts, and will include input from Participants in such forecasts when provided. These forecasts include the active day, day-ahead, week-ahead and month-ahead time frames. The active-day forecasts are used to balance Pool load and system sales and/or purchases in the CAISO intra-day markets. The day-ahead forecasts are used to balance Pool load and system sales and/or purchases in the CAISO day- ahead markets. The rolling week-ahead forecasts are submitted to the CAISO on a daily basis as required by the CAISO Tariff and the MSS Agreement. The month-ahead forecasts are used to develop pre-month scheduling plans. Monthly forecasts will integrate information included in the long-term and short- term forecasts, and will include information such as current weather information, economic and demographic data, and will include other relevant factors and inputs provided by the Participants.
Short-Term Forecasts. At least [***] prior to the first day of each succeeding Calendar Quarter, King shall furnish Supplier with a rolling forecast of the quantities of each Product, (i) Ramipril in powder form and (ii) Ramipril in PC granules form, by kg, that King intends to order by month, during the [***] period commencing with that Calendar Quarter. Subject to the provisions of Section 2.9 and to the extent Supplier can supply any quantities in excess of the Annual Committed Quantity, such forecasts shall constitute binding commitments of King to purchase the percentages of Products set forth below pursuant to firm orders issued in accordance with Section 2.
Short-Term ForecastsWithin thirty (30) days from the execution -------------------- of the Agreement and, at least ninety (90) days prior to the first day of each succeeding calendar quarter, XXXXXXX shall furnish HMRI with a rolling forecast of the quantities of PRODUCT by SKU that XXXXXXX intends to order by month, during the eighteen (18) month period commencing with that calendar quarter. Such forecasts shall constitute binding commitments of XXXXXXX to purchase the percentages of PRODUCT set forth below pursuant to firm orders issued in accordance with Section 2.4. Such forecasts shall not exceed HMRI's maximum annual capacity as set forth in Section 2.7(a). However, HMRI will use its best efforts to fill orders by XXXXXXX in excess of such forecasts. XXXXXXX shall be required to purchase that percentage of the quantity of PRODUCT specified in the forecast for successive quarters as follows: Period of the Forecast Percentage of PRODUCT by SKU that XXXXXXX is Required to Purchase Immediate Three Month Period 100% Second Three Month Period 75% Third Three Month Period 25% Fourth Three Month Period 0%
Short-Term Forecasts. Upon execution of this AGREEMENT, and thereafter no later than the tenth (10th) calendar day of any calendar month (the "FORECAST MONTH") (with the previous month's forecast to govern in the event of the failure or delay of such delivery), MEDICIS shall deliver to HMRI a rolling monthly forecast of the quantities of LOPROX LOTION, by finished dosage form and package size (SKU), that MEDICIS intends to order during the ensuing twenty-four (24) month period (including the FORECAST MONTH) after receipt by HMRI of the forecast. It is acknowledged that the monthly forecasts in the 24-MONTH FORECAST for the period from the LICENSE EFFECTIVE DATE through the end of the third (3rd) full calendar month following the LICENSE EFFECTIVE DATE shall constitute confirmed MEDICIS orders for purposes of this AGREEMENT. HMRI may, by notice to MEDICIS given within ten (10) business days following its receipt of a forecast, elect not to confirm, in whole or in part, the forecast for the third calendar month after the FORECAST MONTH which (i) is made at a time when HMRI has the right to suspend the provision of LOPROX LOTION pursuant to Section 2.12(b) hereof, (ii) cannot be filled due to circumstances arising under Section 8.1 hereof, (iii) are in excess of the quantities forecasted by MEDICIS in the 24-MONTH FORECAST (which quantities HMRI may, at its option, apportion pro rata among each month in a calendar quarter in the 24 MONTH FORECAST for purposes of this clause), or (iv) relates to any period of time beyond the 24-MONTH FORECAST. All rejections, in whole or in part, of MEDICIS orders by HMRI must be in writing and delivered within such ten (10) business day period. Unless so rejected by HMRI, the forecast for such third (3rd) calendar month after the FORECAST MONTH shall become a binding obligation on MEDICIS to purchase, and a binding obligation on HMRI to supply, such quantities. MEDICIS' first short term forecast (the "24-MONTH FORECAST") is attached hereto as Exhibit D. Unless mutually agreed by HMRI and MEDICIS in writing, the monthly forecast submitted by MEDICIS for such third calendar month shall be at least eighty per cent (80%) and not be more than one hundred twenty per cent (120%) of the most recent forecast for such third calendar month provided to HMRI pursuant to Section 2.4(a) hereof.